|
|
|
Prenetics Global Ltd | 6.50% Series G Cumulative Redeemable Preferred Shares (PRE.PRG)
Prospectus excerpt: The 6.50% Series G Cumulative Redeemable Preferred Shares shall have the designation, preferences and rights, and shall be subject to the restrictions, as hereinafter appearing: Section 1. Designation and Amount. There shall be a series of Preferred Shares of the Company which shall be designated as Ù6.50% Series G Cumulative Redeemable Preferred Shares,ˆ par value $1.00 per share (hereinafter called ÙSeries G Preferred Sharesˆ), and the number of shares constituting such series shall be 9,200,000. Such number of shares may be increased or decreased at any time and from time to time by resolution of the Company?s Board of Directors; provided, however, that no decrease shall reduce the number of shares of Series G Preferred Shares to a number less than that of the shares then outstanding plus the number of shares of Series G Preferred Shares issuable upon exercise of outstanding rights, options or warrants or upon conversion of outstanding securities issued by the Company. Full Prospectus PDF », Secondary Prospectus PDF », PRE Page »
Series: | G | Alternate symbology: | PRE-G, PRE-PG, PREprG | Redeemable?: | Yes | Call Date: | 6/1/2021 (Now Trading Post Call Date) | Perpetual?: | Yes | Cumulative?: | Yes | Shares Offered: | 9,200,000 | Liquidation Preference: | $25.00 | Original Coupon: | 6.50% | Pay Period: | Quarterly | Pay Dates: | 1-Mar, 1-Jun, 1-Sep, 1-Dec | CDx3 Compliance Rating: |
Learn PRE.PRG's Rating
|
|
Prenetics Global is a holding company. Through its subsidiary, Prenetics Holding Company Limited, Co. is a diagnostics and genetics testing products and services provider. Co.'s pipeline products and services include: ColoClear, which is a non-invasive fecal immunochemical test and multi-target stool-based DNA testing colorectal cancer screening test; Circle SnapShot, which is an off-the-shelf at-home blood test where individuals can get digital access to their own health information; and Circle One, F1x and Fem, which develop to provide its customers personalized nutrition, hair loss and sexual health products tailored to each of its customer's genetic variation and biology. Preferreds: PRE.PRC, PRE.PRD, PRE.PRE, PRE.PRF, PRE.PRG, PRE.PRH, PRE.PRI, PRE.PRJ Open the PRE Information Page »
|
|
|
|
|